Back to Results
First PageMeta Content
Federal Trade Commission / Disgorgement / Damages / Legal remedy / Government / Business / Judicial remedies / Corporate crime / United States antitrust law


Separate Statement of Commissioners Maureen K. Ohlhausen and Joshua D. Wright
Add to Reading List

Open Document

File Size: 45,02 KB

Share Result on Facebook

Company

Cardinal Health Inc. / Mylan Labs. / See Apotex Inc. / Teva / Valley Drug Co. / Cephalon Inc. / /

Currency

USD / /

IndustryTerm

case law / remedial tool / antitrust law / /

Organization

US Federal Reserve / European University Institute Department of Law Annual Workshop / Federal Trade Commission / Department of Justice / /

Person

Douglas H. Ginsburg / Bruce H. Kobayashi / Joshua D. Wright / Maureen K. Ohlhausen / Joanna Tsai / Thomas B. Leary / Maureen K. Ohlhausen Dissenting / /

Position

Commissioner / /

Product

Tamoxifen Citrate / Ciprofloxacin Hydrochloride / /

Technology

pdf / /

URL

www.ftc.gov/system/files/documents/public_statements/637761/150420cardinalhealthohlhausen.p / www.ftc.gov/system/files/documents/public_statements/637771/150420cardinalhealthwright.pdf / www.ftc.gov/publicstatements/2012/07/statement-commission-regarding-withdrawal-commissions-policy-statement / www.ftc.gov/sites/default/files / www.ftc.gov/public-statements/2012/07/statement-commissioner-maureen-k-ohlhausendissenting-commissions-decision / www.ftc.gov/system/files/documents/public_statements/296171/120731commstmtmonetaryremedies.pdf / www.ftc.gov/sites/default/files/documents/cases/2000/11/mylanlearystatment.htm / /

SocialTag